High prevalence of mild hyperhomocysteinemia and folate, B12 and B6 deficiencies in an urban population in Karachi, Pakistan

Pakistan Journal of Medical Sciences

Volumn 26, Issue 4, 2010, Pages 923-929

  Yakub, Mohsin ^a   Iqbal, Mohammad Perwaiz ^a   Kakepoto, Ghulam Nabi ^a   Rafique, Ghazala ^a   Memon, Yousuf ^a   Azam, Iqbal ^a   Mehboobali, Naseema ^a   Parveen, Siddiqa ^a   Haider, Ghulam ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Cardiovascular diseases; Folate deficiency; Hyperhomocysteinemia; Vitamin B12 deficiency; Vitamin B6 deficiency

Indexed keywords

EID: 79956102373     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. nd ed. Paris, Springer 2002.
2. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
3. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833-43.
4. Ahmad K. Facing up to Pakistan's cardiovascular challenge. Lancet 2002;359:859.
5. Iqbal MP, Ishaq M, Kazmi KA, Yousuf FA, Mehboobali N, Ali SA, et al. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction. Nutr Metab Cardiovas Dis 2005;15:100-108.
6. Iqbal MP, Lindblad BS, Mehboobali N, Yusuf FA, Khan AH, Iqbal SP. Folic acid and vitamin B6 deficiencies related hyperhomocysteinemia in apparently healthy Pakistani adults: Is mass micronutrient supplementation indicated in this population. J Coll Physicians Surg Pak 2009;19:308-312.
7. Yakub M, Iqbal MP. Association of blood lead (Pb) and plasma homocysteine: A cross sectional survey in Karachi, Pakistan. PLoS ONE 2010;5(7):e11706. doi:101371/ journal.pone.0011706.
8. Chanarin I. Laboratory Haematology. New York: Churchill Livingstone 1989;130-137.
9. Quadros EV. Vitamin B12. In: Song WO, Beecher JR, Eitenmiller RR, editors. Modern Analytical Methodologies in Fat and Water-Soluble Vitamins. Chemical Analysis Series. Vol 154. New York: John Wiley 2000;311-26.
10. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of plasma pyridoxal 5́-phosphate. Clin Chem 1983;29:642-644.
11. Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart disease; B-vitamins and hommocysteine. Circulation 1998;97421-424.
12. Sastry BK, Indira N, Anand B, Kedarnath Prabha BS, Raju BS. A case-control study of plasma homocysteine levels in South Indians with and without coronary artery disease. Indian Heart J 2001;53:749-753.
13. Aamir M, Sattar A, Dawood MM, Dilawar M, Ijaz A, Anwar M, Hyperhomocysteinemia as a risk factor for ischemic heart disease. J Coll Physician Surg Pak 2004;14:518-521.
14. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F, et al. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults, the Tehran homocysteine Survey (2003-2004)/a cross-sectional population based study. BMC Public Health 2006;13:6:29.
15. Misra A, Vikram NK, Pandey RM, Dwivedi M, Ahmad FU, Luthra K, et al. Hyperhomocysteinemia and low intake of folic acid and vitamin B12 in urban North India. Eur J Nutr 2002;41:68-77.
16. Yajnik CS, Deshpande SS, Lubree HG, Naik SS, Bhat DS, Uradey BS, et al. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India 2006;54:775-82.
17. National Health Survey of Pakistan 1990-94. Pakistan Medical Research Council, Islamabad, Pakistan.
18. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations, An expert opinion. Clin Chem 2004;50:3-32.
19. Zeng XK, Remick DG, Wang X. Homocysteine induces production of monocyte chemoathractant protein-1 and interleukin-8 in cultured human whole blood. Acta Pharmcol Sin 2004;25(11):1419-25.
20. Rasouli ML, Nasir K, Blumenthal RS, Park R, Aziz DC, Budoff MJ. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005;181(1):159-65.
21. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases, a meta-analysis of randomized control trials. JAMA 2006;296:2720-2726.
22. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 2008;299:2027-2036.
23. Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E. Heart Outcomes Prevention Evaluation 2 Investigators. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 2009;40:1365-1372.
24. SEARCH Collaborative Group. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: A randomized trial. JAMA 2010;303:2486-2494.
25. Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomized, placebo-controlled trial. Lancet 2000;355(9203):517-522.
26. Vermeulen EG, Stehouwer CD, Valk J, van der Knaap M, Twisk JW et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: A placebo-controlled, randomized trial. Eur J Clin Invest 2004;34(4):256-261.